Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
American Association for Cancer Research
Pharma
AACR: Novartis makes case for canakinumab in lung cancer
The most important sign from the failed metastatic NSCLC trial that gives Novartis hope in the adjuvant setting lies in a subgroup analysis.
Angus Liu
Apr 12, 2022 4:05pm
AACR: Amgen fortifies KRAS lung cancer case with 2-year data
Apr 10, 2022 12:00pm
BMS, clinging to Opdivo's lung share, highlights long-term data
Apr 3, 2019 11:09am
Clovis' Rubraca puts up positive phase 2 pancreatic cancer data
Apr 2, 2019 8:30am
Merck's Keytruda holds its own in tough lung cancer subgroups
Apr 1, 2019 8:30am
Astellas pads Xospata lead with AML survival data
Apr 1, 2019 8:30am
